Loading…
Employees: 1,370
Size Trualt Bioenergy (TRUALT.NS) is an India Materials company (Chemicals: Specialty) with a market value of $320M, the 1033rd largest of 1,058 India companies the cockpit tracks. Shares closed at ₹353.25 on 6 Nov 2026.
Performance Over six months the shares fell 25.9%, against -23.2% for the median peer and 0.0% for the India market (cap-weighted) — 10th lowest of 21 in its peer set.
Growth Revenue fell 5.2% over the last twelve months (peer median +4.3%); the operating margin is 14.3% (peer median 2.3%).
Valuation It trades at 10.4× forward earnings against a peer median of 12.4× (4th cheapest of 8).
Capital Return on invested capital runs 0.3 points above its cost of capital (8.5% WACC).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹27.5B | ₹16.7B | ₹17.6B | ₹12.2B | ₹7.62B |
| Revenue growth | — | -5% | +44% | +60% | — |
| Gross profit | ₹7.92B | ₹2.59B | ₹2.32B | ₹1.88B | ₹1.36B |
| EBITDA | ₹4.87B | ₹2.36B | ₹1.65B | ₹1.88B | ₹1.05B |
| Net income | ₹2.21B | ₹959M | ₹1.47B | ₹318M | ₹355M |
| Free cash flow | n/a | -₹9.59B | -₹562M | -₹4.24B | -₹420M |
| Capital expenditure | n/a | ₹5.11B | ₹2.60B | ₹3.57B | ₹2.76B |
| Total debt | ₹16.6B | ₹16.5B | ₹15.6B | ₹16.8B | ₹11.5B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | TRUALT.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -21.3% | -15.5% | 5th lowest of 21 |
| 6-month return | -25.9% | -23.2% | 10th lowest of 21 |
| Distance from 52-week high | -34.8% | -47.4% | 4th highest of 21 |
| Revenue growth (TTM) | -5.2% | +4.3% | 4th lowest of 21 |
| Operating margin | 14.3% | 2.3% | 3rd highest of 21 |
| Forward P/E | 10.4× | 12.4× | 4th cheapest of 8 |
| ROIC minus cost of capital | +0.3 pp | -3.6 pp | 7th highest of 20 |
| EV / EBITDA | 9.7× | 8.0× | 4th most expensive of 8 |
| Net debt / EBITDA | 3.4× | 2.6× | 4th most indebted of 9 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Trualt Bioenergy TRUALT.NS | India | $320M | -26% | -5% | 14% | 10.4× | n/a | n/a |
| Weifang Yaxing Chemical 600319.SS | China | $320M | -32% | -5% | -10% | n/a | n/a | n/a |
| Jiangmen Kanhoo Industry 300340.SZ | China | $318M | -31% | +20% | -7% | n/a | 51.6% | +4.7% |
| Chung Hwa Chemical Industrial Works 1727.TW | Taiwan | $325M | -4% | +5% | 5% | n/a | n/a | n/a |
| Yangfan New Materials (Zhejiang) 300637.SZ | China | $314M | -19% | +3% | 1% | n/a | 57.5% | +13.4% |
| Aekyung Chemical 161000.KS | South Korea | $326M | -41% | +3% | 2% | n/a | n/a | n/a |
| PCC Rokita Spolka Akcyjna PCR.WA | Poland | $327M | -7% | -6% | 3% | 10.2× | 16.1% | +4.1% |
| Anhui Annada Titanium Industry 002136.SZ | China | $327M | -33% | +12% | 2% | n/a | n/a | n/a |
| Suzhou Fushilai Pharmaceutical 301258.SZ | China | $313M | -21% | -15% | -13% | n/a | n/a | n/a |
| Guangdong Quanwei Technology 300716.SZ | China | $331M | +2% | +47% | -333% | n/a | n/a | n/a |
| Stella Chemifa 4109.T | Japan | $332M | -22% | +4% | 12% | 14.7× | 6.5% | +2.3% |
| Jiangsu HSC New Energy Materials 688353.SS | China | $332M | -35% | +153% | 39% | 12.9× | n/a | n/a |
| Shenzhen Tongyi Industry 300538.SZ | China | $307M | -31% | -16% | -2% | n/a | n/a | n/a |
| PI Advanced Materials 178920.KS | South Korea | $307M | -45% | -2% | 22% | 8.2× | -9.5% | +0.1% |
| Wuxi Honghui New Materials Technology 002802.SZ | China | $307M | -17% | +8% | 13% | n/a | 11.5% | -6.2% |
| Longxing Technology 002442.SZ | China | $335M | -27% | +7% | 1% | n/a | n/a | n/a |
| Tomoe Engineering 6309.T | Japan | $336M | +3% | +2% | 9% | 12.4× | n/a | n/a |
| Zhejiang Wanfeng Chemical 603172.SS | China | $338M | -22% | +17% | 11% | n/a | n/a | n/a |
| Liuzhou Chemical Industry 600423.SS | China | $299M | -19% | +3% | -15% | n/a | 38.2% | +5.2% |
| Rasa Industries,Ltd 4022.T | Japan | $298M | -44% | +13% | 13% | 9.0× | 6.4% | +10.5% |
| Gevo GEVO | United States | $344M | -24% | +121% | -30% | 30.2× | n/a | n/a |